Skip to content
lifestyle.thedailyhaze.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
XVIVO Perfusion AB
XVIVO Receives CE Certificates for Its Groundbreaking Heart Preservation Technology, Transforming Access to Life-Saving Transplants Across Europe
August 11, 2026
XVIVO Granted Additional Patient Enrollment in the US PRESERVE CAP Study for XVIVO Heart Assist Transport
August 3, 2026
Conference call on Interim Report April-June 2026
June 26, 2026
Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO’s Heart Technology
May 23, 2026
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
April 29, 2026
Interim Report January – March 2026
April 28, 2026
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation
April 28, 2026
Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO’s Heart Technology Presented at ISHLT in Toronto
April 28, 2026
Conference Call on Interim Report January-March 2026
April 17, 2026
The 12-Month Follow-up Results from XVIVO’s European Multicenter Heart Trial is Now Published in the European Heart Journal
April 16, 2026
1
2
Next Page
→